£52.00

It has never been this cheap. We have no record of a lower price.

£52 today · cheaper than every other day in the last 3 months

Inibidores da fosfolipase A2 como moléculas anti-inflamatórias

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 34 days · 34 data points (no recent data)

Historical
Generating forecast…
£52.00 £49.40 £50.44 £51.48 £52.52 £53.56 £54.60 12 August 2026 20 August 2026 28 August 2026 05 September 2026 14 September 2026
View at Amazon ↗

Price data last checked 57 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 34 days • 1 price levels

Days at Price
34 days 0 9 17 26 34 £52 Days at Price

Price Analysis

Most common price: £52 (34 days, 100.0%)

Price range: £52 - £52

Price levels: 1 different prices over 34 days

Description

A fosfolipase A2 secretora é uma enzima reguladora crucial no início de qualquer reação inflamatória, produzindo vários mediadores lipídicos pró-inflamatórios e espécies reactivas de oxigénio. O nível elevado de sPLA2 é registado em todas as condições fisiopatológicas. Durante o processo de cicatrização, esta enzima deve ser desregulada, caso contrário, as reacções inflamatórias defensivas tornam-se potencialmente nocivas e acabam em várias doenças inflamatórias crónicas que põem a vida em risco. As espécies reactivas de oxigénio produzidas durante as lesões e infecções activam a enzima PLA2, agravando assim a situação. Os fortes estímulos descontrolados das reacções inflamatórias em curso são controlados por medicamentos anti-inflamatórios. Existem muitas formas de reduzir a inflamação e os seus danos no sistema humano. Os glucocorticosteróides e os agentes anti-inflamatórios não esteróides têm sido utilizados durante décadas como medicamentos anti-inflamatórios, apesar de terem efeitos secundários consideráveis no corpo humano. A partir de estudos clínicos, foi sugerido que os inibidores das enzimas inflamatórias PLA2 são terapeuticamente poderosos como medicamentos anti-inflamatórios.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
20 January 2025
Listed Since
21 January 2025

Barcode

No barcode data available

Similar Products You Might Like

Inflammation
75% match

Inflammation

Springer

£123.72 22 Oct 2026
Proteases and Their Receptors in Inflammation (Progress in Inflammation Research)
75% match

Proteases and Their Receptors in Inflammation (Progress in Inflammation Research)

Springer

£94.29 15 Sep 2026
New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules Proceedings of a conference held on April 15–16, 1996, in New Orleans, USA, ... educational grant from Boehringer Ingelheim
75% match

New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules Proceedings of a conference held on April 15–16, 1996, in New Orleans, USA, ... educational grant from Boehringer Ingelheim

Springer

£76.42 25 Oct 2026
Inflammation
75% match

Inflammation

Springer

£124.36 12 Sep 2026
Mediadores inflamatórios na patogénese da periodontite
75% match

Mediadores inflamatórios na patogénese da periodontite

£66.00 14 Sep 2026
Proteases and Their Receptors in Inflammation (Progress in Inflammation Research)
75% match

Proteases and Their Receptors in Inflammation (Progress in Inflammation Research)

Springer

£113.76 22 Oct 2026
Inflammasomes: Clinical and Therapeutic Implications: 108 (Experientia Supplementum, 108)
74% match

Inflammasomes: Clinical and Therapeutic Implications: 108 (Experientia Supplementum, 108)

Springer

£112.48 27 Oct 2026
Inflammasomes: Clinical and Therapeutic Implications: 108 (Experientia Supplementum, 108)
73% match

Inflammasomes: Clinical and Therapeutic Implications: 108 (Experientia Supplementum, 108)

Springer

£113.49 23 Oct 2026
The Inflammasomes (Progress in Inflammation Research)
73% match

The Inflammasomes (Progress in Inflammation Research)

Springer

£108.33 22 Oct 2026
Papel dos Polimorfismos Genéticos: na Via das Quimiocinas na Asma e Atopia
72% match

Papel dos Polimorfismos Genéticos: na Via das Quimiocinas na Asma e Atopia

£64.51 15 Sep 2026
Arachidonate Remodeling and Inflammation (Progress in Inflammation Research)
72% match

Arachidonate Remodeling and Inflammation (Progress in Inflammation Research)

Birkhauser

£75.87 25 Oct 2026
Purification et caractérisation des phospholipase du venin de scorpion
72% match

Purification et caractérisation des phospholipase du venin de scorpion

ÉDITIONS UNIVERSITAIRES EUROPÉENNES

£48.00 14 Sep 2026
Inflammation: 50 / 1 (Handbook of Experimental Pharmacology, 50 / 1)
72% match

Inflammation: 50 / 1 (Handbook of Experimental Pharmacology, 50 / 1)

Springer

£77.74 03 Nov 2026
COX-2 Inhibitors (Milestones in Drug Therapy)
72% match

COX-2 Inhibitors (Milestones in Drug Therapy)

Birkhauser

£108.70 23 Oct 2026
A estafiloxantina, um antioxidante, no stress induzido por CCl₄ em ratos albinos
71% match

A estafiloxantina, um antioxidante, no stress induzido por CCl₄ em ratos albinos

£58.00 15 Sep 2026
COX-2 Blockade in Cancer Prevention and Therapy (Cancer Drug Discovery and Development)
71% match

COX-2 Blockade in Cancer Prevention and Therapy (Cancer Drug Discovery and Development)

Humana

£80.67 21 Oct 2026
Springer Compendium of Inflammatory Diseases - Medical Text
71% match

Springer Compendium of Inflammatory Diseases - Medical Text

Springer

£651.93 09 Nov 2026
Molecular Basis of Health and Disease
71% match

Molecular Basis of Health and Disease

Springer

£137.41 21 Oct 2026
New Cytokines as Potential Drugs (Progress in Inflammation Research)
71% match

New Cytokines as Potential Drugs (Progress in Inflammation Research)

Birkhauser

£73.85 22 Oct 2026
Pharmacology of Immunotherapeutic Drugs
71% match

Pharmacology of Immunotherapeutic Drugs

Springer

£73.14 22 Oct 2026
LES DÉRIVÉS PLAQUETTAIRES ET LEURS IMPLICATIONS CLINIQUES: Dérivés plaquettaires
71% match

LES DÉRIVÉS PLAQUETTAIRES ET LEURS IMPLICATIONS CLINIQUES: Dérivés plaquettaires

£52.00 14 Sep 2026
Antibiotics as Anti-Inflammatory and Immunomodulatory Agents (Progress in Inflammation Research)
71% match

Antibiotics as Anti-Inflammatory and Immunomodulatory Agents (Progress in Inflammation Research)

Birkhauser

£107.57 21 Oct 2026
Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential
70% match

Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential

Springer

£106.99 25 Oct 2026
Molecular and Cellular Basis of Inflammation (Current Inflammation Research)
70% match

Molecular and Cellular Basis of Inflammation (Current Inflammation Research)

Humana

£32.90 14 Sep 2026